Abstract
The International Society on Thrombosis and Hemostasis bleeding assessment tool (ISTH-BAT) was developed to record bleeding symptoms and aid in patient diagnosis. This study was done to investigate the utility of ISTH-BAT in patients suspected to have inherited bleeding disorders. This cross-sectional study was conducted in a tertiary care hospital in Southern India over 3 and 1/2 years. A trained investigator administered the ISTH-BAT questionnaire to 432 patients undergoing evaluation for inherited bleeding disorder prior to routine coagulation screening and confirmatory tests and to 131 healthy volunteers as controls. Among patients, 42(9.7%) had primary hemostatic defect, 150(34.7%) had secondary hemostatic defects and 229(53%) had normal screening coagulogram with mean bleeding scores (BS) being 5.9, 6.9, and 4.2 respectively and the proportion of patients with abnormal BS being 69%, 88.7% and 59.4% respectively; the latter qualifying as unknown hemostatic defect. 11(2.5%) with acquired hemostatic defect on workup were excluded. The mean BS was 1.52 among healthy volunteers. Common bleeding patterns were epistaxis (73.8%), cutaneous bleeding (52.4%), hematuria (54.8%), menorrhagia (50%) in primary hemostatic defect; cutaneous bleeding (72%), muscle hematoma (58.7%), hemarthrosis (46.7%), menorrhagia (58.7%) in secondary hemostatic defects and epistaxis (45.9%), cutaneous bleeding (62.4%), menorrhagia (30.7%) in normal screening coagulogram group. Grade of bleeding was mostly 2 and sometimes 4 in primary, 2–4 in secondary and 1–2 in normal screening coagulogram group. ISTH-BAT is a valuable tool to record lifelong bleeding history. The pattern and score give clues regarding the nature and severity of the bleeding disorder.
Similar content being viewed by others
References
Rydz N, James PD (2012) The evolution and value of bleeding assessment tools. J Thromb Haemost 10:2223–2229
Sramek A Sr, Eikenboom JC, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Usefulness of patient interview in bleeding disorders. Arch Intern Med 155:1409–1415
Rodeghiero F, Tosetto A, Castaman G (2007) How to estimate bleeding risk in mild bleeding disorders. J Thromb Haemost 5:157–166
Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A (2005) The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 3:2619–2626
Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, Peake I (2006) A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 4:766–773
Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD (2009) Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 7:1418–1421
Sadler JE, Rodeghiero F (2005) Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 3:775–777
Boender J, Kruip MJHA, Leebeek FWG (2016) A diagnostic approach to mild bleeding disorders. J Thromb Haemost 14:1507–1516
Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D, ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group (2010) ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 8:2063–2065
Elbatarny M, Mollah S, Grabell J, Bae S, Deforest M, Tuttle A, Hopman W, Clark DS, Mauer AC, Bowman M, Riddel J, Christopherson PA, Montgomery RR, Zimmerman Program Investigators, Rand ML, Coller B, James PD (2014) Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia 20:831–835
Thomas W, Downes K, Desborough MJR (2020) Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and management. Haemophilia 26(6):946–957
Perez Botero J, Warad DM, He R, Uhl CB, Tian S, Otteson GE, Barness RL, Olson MC, Gossman SC, Charlesworth JE, Nichols WL, Pruthi RK, Chen D (2017) Comprehensive platelet phenotypic laboratory testing and bleeding history scoring for diagnosis of suspected hereditary platelet disorders: a single-institution experience. Am J Clin Pathol 148:23–32
Lowe GC, Lordkipanidze M, on behalf of the UK GAPP study group, Watson SP (2013) Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. J Thromb Haemost 11:1663–1668
Adler M, Kaufmann J, Alberio L, Nagler M (2019) Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders. J Thromb Haemost 17(7):1104–1112
Gebhart J, Hofer S, Panzer S, Quehenberger P, Sunder-Plassmann R, Hoermann G, Eigenbauer E, Haslacher H, Kepa S, Kyrle PA, Eichinger S, Knöbl P, Eischer L, Mannhalter C, Ay C, Pabinger I (2018) High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: results from the Vienna Bleeding Biobank (VIBB). Haemophilia 24(3):405–413
Quiroga T, Goycoolea M, Panes O, Aranda E, Martínez C, Belmont S, Muñoz B, Zúñiga P, Pereira J, Mezzano D (2007) High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 92(3):357–365
Tosetto A, Castaman G, Rodeghiero F (2013) Bleeders, bleeding rates, and bleeding score. J Thromb Haemost 11(Suppl 1):142–150
Tosetto A, Castaman G, Plug I, Rodeghiero F, Eikenboom J (2011) Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. J Thromb Haemost 9:1143–1148
Federici AB, Bucciarelli P, Castaman G, Mazzucconi MG, Morfini M, Rocino A, Schiavoni M, Peyvandi F, Rodeghiero F, Mannucci PM (2014) The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease. Blood 123:4037–4044
Vries MJ, van der Meijden PE, Kuiper GJ, Nelemans PJ, Wetzels RJ, van Oerle RG, Lancé MD, Ten Cate H, Henskens YM (2018) Preoperative screening for bleeding disorders: a comprehensive laboratory assessment of clinical practice. Res Pract Thromb Haemost 2(4):767–777
Fasulo MR, Biguzzi E, Abbattista M, Stufano F, Pagliari MT, Mancini I, Gorski MM, Cannavò A, Corgiolu M, Peyvandi F, Rosendaal FR (2018) The ISTH Bleeding Assessment Tool and the risk of future bleeding. J Thromb Haemost 16(1):125–130
Acknowledgements
The authors acknowledge Mr. Sankar Perumal, Technical Officer, Department of Pathology, JIPMER for coagulation laboratory services, Mr. V. Balachandar, Research Assistant and Dr. Sitanshu Sekhar Kar, Additional Professor, Department of PSM, JIPMER for help in data analysis
Funding
This study was funded by JIPMER Intramural Grant for Ph.D. project.
Author information
Authors and Affiliations
Contributions
PLA administered the questionnaire, performed the bench work and prepared the manuscript; DB co-guided the study and reviewed the manuscript; SCN reviewed the study periodically, provided critical inputs and reviewed the manuscript; RK conceptualized and guided the study, analyzed the results and edited the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that they have no conflict of interest.
Ethical Approval
This study was approved by the Institute Ethics Committee (JIP/IEC/2015/13/540 dated 23.04.15).
Ethical Standards
This study was conducted on patients who were enrolled in routine diagnostic care who were administered a questionnaire prior to their routine sampling. Healthy volunteers were administered the questionnaire. All were in accordance with the ethical standards of the Institute ethics committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed written consent was obtained from the adult patients and from the parent or legal guardian for pediatric patients enrolled in the study according to Institute ethical guidelines.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Preliminary data from the study were presented as posters in the ISTH SSC Meeting in Montpelier, France, 2016 and in Platelet Society meeting in Jesus College, Cambridge, 2019.
Rights and permissions
About this article
Cite this article
Ambika, P.L., Basu, D., Nair, S.C. et al. Utility of International Society on Thrombosis and Hemostasis Bleeding Assessment Tool (ISTH-BAT) in Patients with Inherited Bleeding Disorders: A Cross-Sectional Study from Southern India. Indian J Hematol Blood Transfus 38, 122–131 (2022). https://doi.org/10.1007/s12288-021-01435-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-021-01435-8